CytoSorbents, Inc.
7 Deer Park Drive
Suite K
Monmouth Junction
New Jersey
08852
United States
Tel: 732-329-8885
Fax: 732-329-8650
Website: http://www.cytosorbents.com/
Email: info@cytosorbents.com
About CytoSorbents, Inc.
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb is CE Mark certified and is currently distributed in 37 countries around the world as a safe and effective extracorporeal cytokine adsorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis, as well as in cancer immunotherapy.YEAR FOUNDED:
February 2012
LEADERSHIP:
Founders: Christian Steiner and Phillip Chan
CEO: Phillip Chan
JOBS:
Please click here for CytoSorbents job opportunities.
FOLLOW CYTOSORBENTS:
Tweets by CytoSorbents
408 articles about CytoSorbents, Inc.
-
CytoSorbents, Inc. Appoints Dr. Joerg Scheier As European Medical Director
4/27/2015
-
CytoSorbents, Inc. To Present At The 14th Annual Needham Healthcare Conference
4/14/2015
-
CytoSorbents, Inc. Issues Responses to Frequently Asked Questions
4/7/2015
-
CytoSorbents, Inc. Reports Record 2014 Revenue
4/1/2015
-
CytoSorbents, Inc. To Report Fiscal 2014 Operating And Financial Results
3/24/2015
-
CytoSorbents, Inc. Plans Robust Agenda At ISICEM 2015
3/13/2015
-
CytoSorbents, Inc. Launches New International CytoSorb Therapy Product Website
3/11/2015
-
CytoSorbents, Inc. Announces FDA Approval To Commence Initial U.S. Cardiac Surgery Study
2/2/2015
-
CytoSorbents, Inc. And Aferetica Introduce CytoSorb® To Italy
1/30/2015
-
CytoSorbents, Inc. Receives $385,000 In Non-Dilutive Funding From The New Jersey Technology Business Tax Certificate Transfer Program
1/23/2015
-
CytoSorbents, Inc. Announces Closing Of Public Offering
1/14/2015
-
CytoSorbents, Inc. To Present at OneMedForum 2015 And Exhibit At The 44th Society Of Critical Care Medicine Congress
1/7/2015
-
CytoSorbents, Inc. Submits IDE Application To FDA For U.S. Cytosorb® Cardiac Surgery Trial
12/30/2014
-
CytoSorbents, Inc. Corporation Begins NASDAQ Trading Today
12/23/2014
-
CytoSorbents, Inc. Appoints Dr. Gregory B. Di Russo As Senior Vice President Of Clinical Development
12/22/2014
-
CytoSorbents, Inc. Receives NASDAQ Listing Approval
12/18/2014
-
CytoSorbents, Inc. Announces Strategic Partnership With Fresenius Medical Care
12/15/2014
-
Recent CytoSorbents, Inc. Case Reports Highlight Its Use To Help Save The Lives Of Critically-Ill Patients
12/10/2014
-
CytoSorbents, Inc. Reports Temporary Change Of Stock Trading Symbol
12/8/2014
-
CytoSorbents, Inc. Teams With Smart Medical Solutions To Distribute Cytosorb In Romania And Moldova
12/5/2014